The page below is a sample from the LabCE course Hemolytic Disease of the Fetus and Newborn. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Hemolytic Disease of the Fetus and Newborn (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 97 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart

Related Uses

RhIg is also indicated in these special circumstances:

  • Antepartum fetomaternal hemorrhage (FMH), suspected or proven as a result of placenta previa, amniocentesis, chorionic villus sampling, cordocentesis, other obstetrical manipulative procedures (eg, external version or abdominal trauma such as may occur in a car accident or fall)
  • Therapeutic abortion
  • Vaginal bleeding during pregnancy
  • Loss, or threatened loss, of fetus at any gestational stage
  • Ectopic pregnancy

For these non-routine indications, depending on the level of medical care the pregnant woman receives or the awareness level of the risks involved, there is increased potential for RhIg to be administered inappropriately or not at all.